Insider · CIK 0001368151
Vincent Capponi
Files at CTSO (Cytosorbents Corp). First filing Dec 15, 2023, latest Sep 16, 2026.
In brief
Vincent Capponi files SEC Form 4 as COO and president at CTSO (Cytosorbents Corp). Since Dec 15, 2023, Vincent Capponi has reported 2 open-market buys worth $38k and 0 open-market sells worth $0, the latest filed on Sep 16, 2026.
A track record needs three past buys with six months of prices behind them; Vincent Capponi has 0, so none is measured yet.
The newest scored trade: bought $13k of CTSO on Sep 14, 2026, filed Sep 16, 2026, scored 38 (weak). In the last 12 months: 1 buy worth $13k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CTSO: Cytosorbents Corp
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 38Weak | Cytosorbents Corp | $13k 2,073 shares | +5% | - | |
| 48Moderate | Cytosorbents Corp | $25k 18,797 shares | +3% | +70% from low-58% from high |
Transactions
Every row this insider has filed, 12 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | CTSO Cytosorbents Corp | POpen-market purchase Common Stock | +1,800 | $6.07 | $11k | 40,114 | 27 d ago |
| Sep 14, 2026 | CTSO Cytosorbents Corp | POpen-market purchase Common Stock | +273 | $5.90 | $1,611 | 40,387 | 27 d ago |
| Aug 8, 2025 | CTSO Cytosorbents Corp | AGrant or award Common Stock | +89,100 | $0.00 | $0 | 766,268 | Aug 8, 2025 |
| Aug 8, 2025 | CTSO Cytosorbents Corp | AGrant or award Stock Option (Right to Buy)derivative | +111,100 | $0.00 | $0 | 111,100 | Aug 8, 2025 |
| Feb 24, 2025 | CTSO Cytosorbents Corp | OOut-of-the-money exercise Common Stock | +12,000 | $1.13 | $14k | 677,168 | Feb 26, 2025 |
| Feb 24, 2025 | CTSO Cytosorbents Corp | OOut-of-the-money exercise Series A Right Warrants (right to buy)derivative | -12,000 | $1.13 | $14k | 0 | Feb 26, 2025 |
| Jan 17, 2025 | CTSO Cytosorbents Corp | XIn-the-money exercise Common Stock | +31,760 | $1.00 | $32k | 665,168 | Jan 22, 2025 |
| Jan 17, 2025 | CTSO Cytosorbents Corp | XIn-the-money exercise Subscription Rights (right to buy)derivative | -31,760 | $0.00 | $0 | 0 | Jan 22, 2025 |
| Jan 17, 2025 | CTSO Cytosorbents Corp | JOther Series A Right Warrantsderivative | +31,760 | - | - | 31,760 | Jan 22, 2025 |
| Jan 17, 2025 | CTSO Cytosorbents Corp | JOther Series B Right Warrantsderivative | +31,760 | - | - | 31,760 | Jan 22, 2025 |
| Dec 13, 2023 | CTSO Cytosorbents Corp | POpen-market purchase Common Stock | +18,797 | $1.33 | $25k | 584,134 | Dec 15, 2023 |
| Dec 13, 2023 | CTSO Cytosorbents Corp | POpen-market purchase Common Stock Warrant (Right to Buy)derivative | +6,578 | - | - | 6,578 | Dec 15, 2023 |
Questions about Vincent Capponi
Answered from the filings on this page, as of the latest one.
Is Vincent Capponi buying or selling?
In the last 12 months Vincent Capponi reported 1 open-market buy worth $13k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $13k of CTSO on Sep 14, 2026. Grants, option exercises and tax withholding are not counted.
How did Vincent Capponi's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Vincent Capponi has 0.
Where does Vincent Capponi file Form 4?
Vincent Capponi has filed Form 4 at CTSO (Cytosorbents Corp) as President & COO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.